Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Coronavirus company news summary – XPhyto signs agreement with German company for Covid-19 PCR test – FDA authorises Enzo’s AMPICOLLECT sample collection kit in the US

22 Apr 2021 (Last Updated April 22nd, 2021 09:47)

XPhyto Therapeutics has signed a distribution, storage and logistics agreement with a German pharmaceutical wholesaler and service provider for the distribution of its diagnostic products. The agreement seals a full-service deal with the company to distribute its 25-minute Covid-19 RT-PCR test called the Covid-ID Lab. The test is registered within the EU as a commercial in vitro diagnostic CE-IVD test.

Enzo Biochem has announced that the US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to its AMPICOLLECT sample collection kit. The test can be used with Enzo’s proprietary GENFLEX molecular diagnostic platform, along with other PCR-based molecular diagnostic platforms or antigen-based testing platforms.

Ceres Nanosciences has been awarded a contract of $8.2m by the US National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative to support the development and execution of wastewater-based surveillance systems for the detection of the SArs-CoV-2 virus. The systems will be powered by the Nanotrap particle technology in various sites with a focus on vulnerable populations.